Xconomy National

Archives

by in

Entry	Author	Date	Location
Cerulean Shows Progress in Cancer, Tests Nano-Drug Platform in RNAi	Arlene Weintraub	07/27/11	Boston
Alnylam Looks to ASCO as First “Bell-Ringing” for RNAi Resurgence	Arlene Weintraub	05/26/11	Boston
Agenda Announced for Most Exciting XSITE Yet: We Got 20-Plus Startups, Founders’ Stories, Incubator Debaters, & Provocative Keynoters	Robert Buderi	05/26/11	Boston
David Cancel, Stephen Kaufer, Katie Rae, and Others Join XSITE Program on June 16	Gregory T. Huang	04/28/11	Boston
What do Desh Deshpande, Gilt Groupe, Nobelist Phil Sharp, & Intellectual Ventures Have in Common? All Are Keynoting at XSITE 2011-The Entrepreneurship Era	Robert Buderi	04/20/11	Boston
Alnylam Named in Complaint Over RNAi Patents	Ryan McBride	03/23/11	Boston
Alnylam Settles One Lawsuit, Hit With Another; Living Proof Raises $16M, Tolerx/GSK Drug Fails to Meet Goal, & More Boston-Area Life Sciences News	Rebecca Zacks	03/18/11	Boston
Epizyme Entices Broad Institute Player, Robert Gould, to Take Over as CEO	Ryan McBride	03/24/10	Boston
Navinet and Vitality use Internet for Health, Constellation Gets to Series A, and Other Boston-Area Life Sciences News	Eric Hal Schwartz	08/19/09	Boston
Next 10 to Sign Up for XSITE 2009 are Eligible to Win a Garmin GPS System—So Hurry Up and Navigate to the Registration Site	Editors	06/09/09	Boston
The Health 2.0 Hub, Boston’s Secret Entertainment Cluster, A Path to Market for Energy Innovations, Dean Kamen, and more XSITEment	Robert Buderi	06/02/09	Boston
Isis, Alnylam to Collaborate on Single-Stranded RNA Drugs; Deal Could Add Up to $31 Million to Isis’ Coffers	Wade Roush	04/29/09	San Diego
Regulus Strikes Out On Its Own, J&J Seeks “Enlight”-enment, Synta Awaits Melanoma Data, & More Boston-Area Life Sciences News	Rebecca Zacks	01/28/09	Boston
Alnylam, Cubist Will Cooperate on RNAi Drug for Lung Infections	Wade Roush	01/09/09	Boston
New RNAi Drugs, Major Cutbacks at Targanta, Big Partnerships for Arqule and Archemix, & More Boston-Area Life Sciences News	Wade Roush	12/24/08	Boston
No Appeal for Boston Scientific, No Luck for CombinatoRx Drug, No Complaints From Harvard, & More Boston-Area Life Sciences News	Rebecca Zacks	10/08/08	Boston
Alnylam Hires Chief Scientist, Jack Schmidt, To Help Build RNAi Pipeline	Luke Timmerman	10/01/08	Boston
Alnylam, RXi On Collision Course Over Intellectual Property From Massachusetts Life Sciences Initiative	Luke Timmerman	09/19/08	Boston
Alnylam Sees Opportunity in Turning Genes On, And Off	Luke Timmerman	09/05/08	Boston
Alnylam’s In the Money: Expects $500 Million in Bank at Year-End	Luke Timmerman	08/06/08	Boston
Alnylam’s Ebola Work Gets $7.5 Million Commitment	Luke Timmerman	08/06/08	Boston
Alnylam Obtains Intellectual Property For RNA Activation, Turning Genes On Instead of Off	Luke Timmerman	08/04/08	Boston
Alnylam, Novartis Extend RNA Interference Collaboration	Luke Timmerman	07/16/08	Boston
Alnylam Loses RNAi Patent in Europe; Analyst Says No Worries	Luke Timmerman	07/11/08	Boston
Alnylam Inks $93M Japanese Deal	Rebecca Zacks	06/19/08	Boston
$400M Contract for Foster-Miller, 65K Order for OLPC, $1B In, $5M Out for Alnylam, & More Deals News	Rebecca Zacks	06/03/08	Boston
Alnylam Inks $1 Billion Deal with Takeda	Gregory T. Huang	05/27/08	Boston
BSX Meets With Much Approval, Biogen and Icahn Set the (Showdown) Date, Fate’s Fate Revealed, Win Free Stuff, & More Life Sciences News	Rebecca Zacks	05/14/08	Boston
Novartis Increases Stake in Alnylam	Wade Roush	05/08/08	Boston
Three Luminaries, Two Third Revolutions, and One Nice Suit: An Xconomy Forum on the Future of Life Sciences in New England	Rebecca Zacks	05/02/08	Boston
Page 1 of 2	next page »